共 50 条
- [41] Safety and efficacy of Korean red ginseng intervention (SAEKI): Results of a randomized, double-blind, placebo-controlled crossover trial in type 2 diabetesDIABETES, 2003, 52 : A137 - A137Vuksan, VSievenpiper, JSung, MKDi Buono, MJenkins, AStavro, PLeiter, LNam, KY
- [42] Henagliflozin monotherapy in patients with type 2 diabetes inadequately controlled on diet and exercise: A randomized, double-blind, placebo-controlled, phase 3 trialDIABETES OBESITY & METABOLISM, 2021, 23 (05): : 1111 - 1120Lu, JumingFu, LiujunLi, YanGeng, JianlinQin, LiLi, PingZheng, HailongSun, ZilinLi, YanbingZhang, LihuiSun, YadongChen, DaoxiongQin, GuijunLu, WeipingGuo, YushanZhang, YuweiLiu, HaiyanZhang, TaoZou, Jianjun
- [43] Efficacy and safety of live varicella zoster vaccine in diabetes: a randomized, double-blind, placebo-controlled trialDIABETIC MEDICINE, 2016, 33 (08) : 1094 - 1101Hata, A.Inoue, F.Hamamoto, Y.Yamasaki, M.Fujikawa, J.Kawahara, H.Kawasaki, Y.Honjo, S.Koshiyama, H.Moriishi, E.Mori, Y.Ohkubo, T.
- [44] Pantoprazole Improves Glycemic Control in Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled TrialJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (11): : E2105 - E2108Singh, Pawan KumarHota, DebasishDutta, PinakiSachdeva, NareshChakrabarti, AmitavaSrinivasan, AnandSingh, InderjeetBhansali, Anil
- [45] A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetesDIABETES OBESITY & METABOLISM, 2010, 12 (12): : 1113 - 1119Rhee, E. J.Lee, W. Y.Yoon, K. H.Yoo, S. J.Lee, I. K.Baik, S. H.Kim, Y. K.Lee, M. K.Park, K. S.Park, J. Y.Cha, B. S.Lee, H. W.Min, K. W.Bae, H. Y.Kim, M. J.Kim, J. A.Kim, D. K.Kim, S. W.
- [46] Efficacy and safety of DBPR108 monotherapy in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled, phase II clinical trialCURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (07) : 1107 - 1115Wang, WeiYao, JunGuo, XiaohuiGuo, YushanYan, ChaoliLiu, KuanzhiZhang, YingWang, XiaoyueLi, HongmeiWen, ZhongyuanWang, XinlingLi, ShuangqingXiao, XinhuaLiu, WeijuanLi, ZilingZhang, LihuiShao, ShiyingYe, HandongQin, GuijunLi, YimingLi, FengZhang, XiaomeiLi, XuefengPeng, YongdeDeng, HongyanXu, XiangjinZhou, LigangHuang, YanliCao, MengyaXia, XuefangShi, MingbiaoDou, JingYuan, Jing
- [47] Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trialDIABETES OBESITY & METABOLISM, 2013, 15 (05): : 432 - 440Kaku, K.Inoue, S.Matsuoka, O.Kiyosue, A.Azuma, H.Hayashi, N.Tokudome, T.Langkilde, A. M.Parikh, S.
- [48] Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trialNATURE MEDICINE, 2022, 28 (05) : 974 - +Yang, WenyingZhu, DalongGan, ShenglianDong, XiaolinSu, JunpingLi, WenhuiJiang, HongweiZhao, WenjuanYao, MinxiuSong, WeihongLu, YibingZhang, XiuzhenLi, HuifangWang, GuixiaQiu, WeiYuan, GuoyueMa, JianhuaLi, WeiLi, ZilingWang, XiaoyueZeng, Jiao'eYang, ZhouLiu, JingdongLiang, YongqianLu, SongZhang, HuiliLiu, HuiLiu, PingFan, KuanluJiang, XiaozhenLi, YufengSu, QingNing, TaoTan, HuiwenAn, ZhenmeiJiang, ZhaoshunLiu, LijunZhou, ZunhaiZhang, QiuLi, XuefengShan, ZhongyanXue, YaomingMao, HongShi, LixinYe, ShandongZhang, XiaomeiSun, JiaoLi, PingYang, TaoLi, Feng
- [49] Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trialNature Medicine, 2022, 28 : 965 - 973Dalong ZhuXiaoying LiJianhua MaJiao’e ZengShenglian GanXiaolin DongJing YangXiaohong LinHanqing CaiWeihong SongXuefeng LiKeqin ZhangQiu ZhangYibing LuRuifang BuHuige ShaoGuixia WangGuoyue YuanXingwu RanLin LiaoWenjuan ZhaoPing LiLi SunLixin ShiZhaoshun JiangYaoming XueHongwei JiangQuanmin LiZongbao LiMaoxiong FuZerong LiangLian GuoMing LiuChun XuWenhui LiXuefeng YuGuijun QinZhou YangBenli SuLongyi ZengHoufa GengYongquan ShiYu ZhaoYi ZhangWenying YangLi Chen
- [50] Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trialNature Medicine, 2022, 28 : 974 - 981Wenying YangDalong ZhuShenglian GanXiaolin DongJunping SuWenhui LiHongwei JiangWenjuan ZhaoMinxiu YaoWeihong SongYibing LuXiuzhen ZhangHuifang LiGuixia WangWei QiuGuoyue YuanJianhua MaWei LiZiling LiXiaoyue WangJiao’e ZengZhou YangJingdong LiuYongqian LiangSong LuHuili ZhangHui LiuPing LiuKuanlu FanXiaozhen JiangYufeng LiQing SuTao NingHuiwen TanZhenmei AnZhaoshun JiangLijun LiuZunhai ZhouQiu ZhangXuefeng LiZhongyan ShanYaoming XueHong MaoLixin ShiShandong YeXiaomei ZhangJiao SunPing LiTao YangFeng Li